Piramal Enterprises is currently trading at Rs. 543.00, up by 7.65 points or 1.43 % from its previous closing of Rs. 535.35 on the BSE.
The scrip opened at Rs. 540.00 and has touched a high and low of Rs. 547.65 and Rs. 537.15 respectively. So far 1121 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 648.30 on 02-Sep-2013 and a 52 week low of Rs. 475.00 on 22-Nov-2012.
Last one week high and low of the scrip stood at Rs. 562.00 and Rs. 533.50 respectively. The current market cap of the company is Rs. 9370.18 crore.
The promoters holding in the company stood at 52.97% while Institutions and Non-Institutions held 30.63% and 16.40% respectively
Ci-Co Healthcare and Piramal Imaging SA, a division of Piramal Enterprises have entered into a strategic partnership and exclusive licensing agreement whereby Ci-Co Healthcare will obtain market authorization from the Korean Health Authorities and commercialize the PET amyloid imaging agent, florbetaben F18, in South Korea. Ci-Co Healthcare has assigned the manufacturing and supply of florbetaben F18 to DuChemBio, a market leading radiopharmacy network in Korea.
Piramal Enterprises is one of India’s largest diversified companies, with a presence in pharmaceutical, financial services and information management sectors.
| Company Name | CMP |
|---|---|
| Bajaj Finance | 917.85 |
| Shriram Finance | 1047.50 |
| Aditya Birla Capital | 340.95 |
| Chola Invest & Fin. | 1573.00 |
| Tata Capital | 337.30 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: